United Health Products, Inc. (UEEC)

United Health Products Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	-	-	0.04	0	0
Revenue Growth (YoY)	-	-	63459.32%	-90.82%	-86.95%
Cost of Revenue	-	-	0.02	0	0
Gross Profit	-	-	0.02	0	0
Selling, General & Admin	1.65	1.83	2.2	29.56	14.6
Research & Development	0.36	0.6	0.62	0.24	0.25
Operating Expenses	2.01	2.43	2.82	29.8	14.85
Operating Income	-2.01	-2.43	-2.8	-29.8	-14.85
Interest Expense	-0.11	-0.12	-0.08	-0.62	-0.55
Other Non Operating Income (Expenses)	-	-	1.01	-	-
EBT Excluding Unusual Items	-2.12	-2.54	-1.87	-30.42	-15.39
Legal Settlements	-	-	0.39	0.3	-
Other Unusual Items	0.12	-0.08	-0.21	-0.43	-0.32
Pretax Income	-2	-2.62	-1.69	-30.55	-15.71
Net Income	-2	-2.62	-1.69	-30.55	-15.71
Net Income to Common	-2	-2.62	-1.69	-30.55	-15.71
Shares Outstanding (Basic)	248	239	230	226	184
Shares Outstanding (Diluted)	248	239	230	226	184
Shares Change (YoY)	3.80%	4.08%	1.76%	22.85%	4.48%
EPS (Basic)	-0.01	-0.01	-0.01	-0.14	-0.09
EPS (Diluted)	-0.01	-0.01	-0.01	-0.14	-0.09
Free Cash Flow	-1.19	-2.2	-0.62	-0.83	-1.43
Free Cash Flow Per Share	-0.01	-0.01	-0.00	-0.00	-0.01
Gross Margin	-	-	50.28%	57.63%	69.67%
Operating Margin	-	-	-7472.10%	-50509550.85%	-2309276.98%
Profit Margin	-	-	-4500.00%	-51778276.27%	-2443452.57%
Free Cash Flow Margin	-	-	-1652.59%	-1403523.73%	-221961.43%
EBITDA	-2	-2.42	-2.8	-	-
D&A For EBITDA	0	0	0	-	-
EBIT	-2.01	-2.43	-2.8	-29.8	-14.85
Advertising Expenses	-	-	-	0.17	0.21

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.